Drug Profile
UK 432097
Alternative Names: UK-432,097Latest Information Update: 03 Oct 2008
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anti-inflammatories; Antiasthmatics
- Mechanism of Action Adenosine A2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 03 Oct 2008 Discontinued - Phase-I for Asthma in Netherlands (Inhalation)
- 03 Oct 2008 Discontinued - Phase-I for Asthma in United Kingdom (Inhalation)
- 03 Oct 2008 Discontinued - Phase-II for Chronic obstructive pulmonary disease in Australia (Inhalation)